CNS T Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

摘要

For use in the treatment of diseases, disorders, conditions or disorders of the CNS that do not comprise autoimmune neuroinflammatory disease, relapsing-remitting multiple sclerosis (RRMS), pharmaceutical agents comprising active agents for reducing systemic immunosuppressive levels in a subject A composition is provided. The pharmaceutical compositions are administered by a regimen comprising at least two treatment courses, each treatment session comprising a rest session followed by a treatment session in sequence.